Surfactant therapy: Past, present and future

Early Human Development

Volumn 89, Issue SUPPL.1, 2013, Pages

  Speer, Christian P ^a   Sweet, David G ^b   Halliday, Henry L ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

Neonates; Respiratory distress syndrome; Surfactant

Indexed keywords

BERACTANT; PHOSPHOLIPID; PORACTANT;

DELIVERY ROOM; DISEASE COURSE; DISEASE SEVERITY; EARLY INTERVENTION; FETUS LUNG MATURITY; HUMAN; META ANALYSIS (TOPIC); NEWBORN DEATH; NEWBORN MORTALITY; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PROPHYLAXIS; RECOMMENDED DRUG DOSE; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK REDUCTION; SUBSTITUTION THERAPY; TREATMENT OUTCOME;

BIOLOGICAL PRODUCTS; DELIVERY ROOMS; GUIDELINES AS TOPIC; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PHOSPHOLIPIDS; PNEUMOTHORAX; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84879836230     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/S0378-3782(13)70008-2     Document Type: Review

References (16)

1. Halliday HL History of surfactant from 1980. Biol Neonate 2005, 87:317-322.
2. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2013 update. Neonatology 2013, 103:353-368.
3. Speer CP, Sweet DG Surfactant replacement: present and future. The Newborn Lung 2012, 283-299. Elsevier Saunders, Philadelphia. 2nd edition. E. Bancalari (Ed.).
4. Speer CP Neonatal respiratory distress syndrome (RDS): an inflammatory disease?. Neonatology 2011, 99:316-319.
5. Singh N, Hawley KL, Viswanathan K Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics 2011, 128:e1588-e1595.
6. Rojas-Reyes MX, Morley CJ, Soll R Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012, (3). CD000510.
7. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, Danish-Swedish Multicenter Study Group, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994, 331(16):1051-1055.
8. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, Colombian Neonatal Research Network, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009, 123:137-142.
9. Kirsten GF, Kirsten CL, Henning PA, Smith J, Holgate SL, Bekker A, et al. The outcome of ELBW infants treated with NCPAP and INSURE in a resource-limited institution. Pediatrics 2012, 129:e952-e959.
10. Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, German Neonatal Network, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011, 378:1627-1634.
11. Dargaville PA Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques. Neonatology 2012, 101(4):326-336.
12. Pillow JJ, Minocchieri S Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology 2012, 101(4):337-344.
13. Wirbelauer J, Speer CP The role of surfactant treatment in preterm infants and term newborn with acute respiratory distress syndrome (ARDS). J Perinatol 2009, 29:S18-S22.
14. Kuo HT, Lin HC, Tsai CH, Chouc IC, Yeh TF A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chonic lung disease in preterm infants. J Pediatr 2010, 156:537-541.
15. Bersani I, Kunzmann S, Speer CP Immunomodulatory properties of surfactant preparations. Expert Rev Anti Infect Ther 2013, 11(1):99-110.
16. Bersani I, Speer CP, Kunzmann S Surfactant protein A and D in pulmonary diseases of preterm infants. Expert Rev Anti Infect Ther 2012, 10(5):573-584.